These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35910798)

  • 21. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
    Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
    Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paradoxical E-cadherin increase in 5FU-resistant colon cancer is unaffected during mesenchymal-epithelial reversion induced by γ-secretase inhibition.
    Dinicola S; Pasqualato A; Proietti S; Masiello MG; Palombo A; Coluccia P; Canipari R; Catizone A; Ricci G; Harrath AH; Alwasel SH; Cucina A; Bizzarri M
    Life Sci; 2016 Jan; 145():174-83. PubMed ID: 26746659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticancer activity of Helicobacter pylori ribosomal protein (HPRP) with iRGD in treatment of colon cancer.
    Yaghoubi A; Asgharzadeh F; Movaqar A; Ghazvini K; Hassanian SM; Avan A; Khazaei M; Soleimanpour S
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):2851-2865. PubMed ID: 34117917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of NOX-2 and Nrf-2 Promotes 5-Fluorouracil Resistance of Human Colon Carcinoma (HCT-116) Cells.
    Waghela BN; Vaidya FU; Pathak C
    Biochemistry (Mosc); 2021 Mar; 86(3):262-274. PubMed ID: 33838628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urolithin A exerts anti-tumor effects on gastric cancer via activating autophagy-Hippo axis and modulating the gut microbiota.
    Qiao Y; Xia Q; Cao X; Xu J; Qiao Z; Wu L; Chen Z; Yang L; Lu X
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep; 397(9):6633-6645. PubMed ID: 38489081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy.
    Grassilli E; Narloch R; Federzoni E; Ianzano L; Pisano F; Giovannoni R; Romano G; Masiero L; Leone BE; Bonin S; Donada M; Stanta G; Helin K; Lavitrano M
    Clin Cancer Res; 2013 Jul; 19(14):3820-31. PubMed ID: 23729362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helminth-derived molecules improve 5-fluorouracil treatment on experimental colon tumorigenesis.
    Mendoza-Rodríguez MG; Medina-Reyes D; Sánchez-Barrera CA; Fernández-Muñoz KV; García-Castillo V; Ledesma-Torres JL; González-González MI; Reyes JL; Pérez-Plascencia C; Rodríguez-Sosa M; Vaca-Paniagua F; Meraz MA; Terrazas LI
    Biomed Pharmacother; 2024 Jun; 175():116628. PubMed ID: 38663106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early-stage colon cancer with high MALAT1 expression is associated with the 5-Fluorouracil resistance and future metastasis.
    Ak Aksoy S; Tunca B; Erçelik M; Tezcan G; Ozturk E; Cecener G; Ugras N; Yilmazlar T; Yerci O
    Mol Biol Rep; 2022 Dec; 49(12):11243-11253. PubMed ID: 35794508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1.
    Xie ZY; Wang FF; Xiao ZH; Liu SF; Tang SL; Lai YL
    J Biochem; 2020 Jun; 167(6):557-564. PubMed ID: 32044957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elucidation of underlying molecular mechanism of 5-Fluorouracil chemoresistance and its restoration using fish oil in experimental colon carcinoma.
    Rani I; Kumar S; Sharma B; Prasad R; Kaur S; Sharma P; Agnihotri N
    Mol Cell Biochem; 2021 Mar; 476(3):1517-1527. PubMed ID: 33392922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of Forkhead Box O3 Facilitates Inflammatory Colon Cancer: Transcriptome Profiling of the Immune Landscape and Novel Targets.
    Penrose HM; Cable C; Heller S; Ungerleider N; Nakhoul H; Baddoo M; Hartono AB; Lee SB; Burow ME; Flemington EF; Crawford SE; Savkovic SD
    Cell Mol Gastroenterol Hepatol; 2019; 7(2):391-408. PubMed ID: 30718226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FOXO3 growth inhibition of colonic cells is dependent on intraepithelial lipid droplet density.
    Qi W; Fitchev PS; Cornwell ML; Greenberg J; Cabe M; Weber CR; Roy HK; Crawford SE; Savkovic SD
    J Biol Chem; 2013 Jun; 288(23):16274-16281. PubMed ID: 23603907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism.
    Larrosa M; González-Sarrías A; Yáñez-Gascón MJ; Selma MV; Azorín-Ortuño M; Toti S; Tomás-Barberán F; Dolara P; Espín JC
    J Nutr Biochem; 2010 Aug; 21(8):717-25. PubMed ID: 19616930
    [TBL] [Abstract][Full Text] [Related]  

  • 34.  Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma.
    Sribenja S; Natthasirikul N; Vaeteewoottacharn K; Sawanyawisuth K; Wongkham C; Jearanaikoon P; Wongkham S
    Ann Hepatol; 2016; 15(4):577-85. PubMed ID: 27236157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditioned media from human macrophages of M1 phenotype attenuate the cytotoxic effect of 5‑fluorouracil on the HT‑29 colon cancer cell line.
    Hedbrant A; Erlandsson A; Delbro D; Wijkander J
    Int J Oncol; 2015 Jan; 46(1):37-46. PubMed ID: 25310018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.
    Oh PS; Patel VB; Sanders MA; Kanwar SS; Yu Y; Nautiyal J; Patel BB; Majumdar AP
    Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G347-55. PubMed ID: 21596996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells.
    González-Sarrías A; Tomé-Carneiro J; Bellesia A; Tomás-Barberán FA; Espín JC
    Food Funct; 2015 May; 6(5):1460-9. PubMed ID: 25857357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ginsenoside Rg3 enhances the anticancer effect of 5‑FU in colon cancer cells via the PI3K/AKT pathway.
    Hong S; Cai W; Huang Z; Wang Y; Mi X; Huang Y; Lin Z; Chen X
    Oncol Rep; 2020 Oct; 44(4):1333-1342. PubMed ID: 32945504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GRP78 Regulates Apoptosis, Cell Survival and Proliferation in 5-Fluorouracil-resistant SNUC5 Colon Cancer Cells.
    Lee JH; Yoon YM; Lee SH
    Anticancer Res; 2017 Sep; 37(9):4943-4951. PubMed ID: 28870916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mice with dysfunctional TGF-β signaling develop altered intestinal microbiome and colorectal cancer resistant to 5FU.
    Wang Z; Hopson LM; Singleton SS; Yang X; Jogunoori W; Mazumder R; Obias V; Lin P; Nguyen BN; Yao M; Miller L; White J; Rao S; Mishra L
    Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166179. PubMed ID: 34082069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.